Asherman's syndrome: current perspectives on diagnosis and management

Eva Dreisler, Jens Joergen Kjer, Eva Dreisler, Jens Joergen Kjer

Abstract

Intrauterine adhesions with symptoms like hypomenorrhea or infertility are known under the term Asherman's syndrome. Although the syndrome has been widely investigated, evidence of both prevention of the syndrome and the ideal treatment are missing. Understanding the pathogenesis of intrauterine adherences is necessary for the prevention of the formation of intrauterine scarring. Intrauterine adhesions can develop from lesion of the basal layer of the endometrium caused by curettage of the newly pregnant uterus. The syndrome may also occur after hysteroscopic surgery, uterine artery embolization or uterine tuberculosis. For initial diagnosis the less invasive contrast sonohysterography or hysterosalpingography is useful. The final diagnosis is based on hysteroscopy. Magnetic resonance imaging is required in cases with totally obliterated uterine cavity. Intrauterine adherences are classified in accordance with different classification systems based on the hysteroscopic diagnosis of severity and localization of adherences. Classification is necessary for the planning of surgery, information on prognosis and scientific purposes. Surgery is performed in symptomatic patients with either infertility or with painful periods. Intrauterine adherences are divided with a hysteroscope using scissors or a power instrument working from the central part of the uterus to the periphery. Peroperative ultrasonography is useful in an outpatient setting for the prevention of complications. Hysteroscopy with fluoroscopy is a solution in difficult cases. Use of intrauterine devices like balloon catheters or intrauterine contraceptive devices seems to be the preferred methods for the prevention of re-occurrence of adhesions after treatment. Both primary prevention after hysteroscopic surgery or curettage and secondary prevention of new adhesions after adhesiolysis have been investigated. The aim of this review was to summarize the literature on diagnosis, classification, treatment and prevention, based on a literature search with a wide range of search terms.

Keywords: Asherman’s syndrome; genital adhesions; gynatresia; intrauterine synechia.

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Selection of relevant papers for the study. Abbreviation: AS, Asherman’s syndrome.

References

    1. Fritsch H. Ein fall von volligen Schwund Der Gebärmutterhohle nACh Auskratzung. Zentralbl Gynaekol. 1894;18:1337–1342.
    1. Asherman JG. Traumatic intra-uterine adhesions. J Obstet Gynaecol Br Emp. 1950;57(6):892–896.
    1. Schenker JG, Margalioth EJ. Intrauterine adhesions: an updated appraisal. Fertil Steril. 1982;37(5):595–610.
    1. Hanstede MMF, van der Meij E, Goedemans L, Emanuel MH. Results of centralized Asherman surgery, 2003–2013. Fertil Steril. 2015;104(6):1561–1568.
    1. Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome – one century later. Fertil Steril. 2008;89(4):759–779.
    1. Diamond MP, Freeman ML. Clinical implications of postsurgical adhesions. Hum Reprod Update. 2001;7(6):567–576.
    1. Hellebrekers BW, Trimbos-Kemper TC, Trimbos JB, Emeis JJ, Kooistra T. Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertil Steril. 2000;74(2):203–212.
    1. Baradwan S, Baradwan A, Al-Jaroudi D. The association between menstrual cycle pattern and hysteroscopic March classification with endometrial thickness among infertile women with Asherman syndrome. Medicine. 2018;97(27):e11314.
    1. Westendorp IC, Ankum WM, Mol BW, Vonk J. Prevalence of Asherman’s syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion. Hum Reprod. 1998;13(12):3347–3350.
    1. Salzani A, Yela DA, Gabiatti JRE, Bedone AJ, Monteiro IMU. Prevalence of uterine synechia after abortion evacuation curettage. Sao Paulo Med J. 2007;125(5):261–264.
    1. March CM, Israel R, March AD. Hysteroscopic management of intrauterine adhesions. Am J Obstet Gynecol. 1978;130(6):653–657.
    1. Hooker AB, Lemmers M, Thurkow AL, et al. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update. 2014;20(2):262–278.
    1. Kjer JJ. Asherman syndrome in a Danish population. Acta Obstet Gynecol Scand. 2014;93(4):425–427.
    1. Chen L, Zhang H, Wang Q, et al. Reproductive outcomes in patients with intrauterine adhesions following hysteroscopic adhesiolysis: experience from the largest women’s hospital in China. J Minim Invasive Gynecol. 2017;24(2):299–304.
    1. Tsapanos VS, Stathopoulou LP, Papathanassopoulou VS, Tzingounis VA. The role of Seprafilm bioresorbable membrane in the prevention and therapy of endometrial synechiae. J Biomed Mater Res. 2002;63(1):10–14.
    1. Hooker AB, de Leeuw R, van de Ven PM, et al. Prevalence of intrauterine adhesions after the application of hyaluronic acid gel after dilatation and curettage in women with at least one previous curettage: short-term outcomes of a multicenter, prospective randomized controlled trial. Fertil Steril. 2017;107(5):1223–1231.
    1. Rein DT, Schmidt T, Hess AP, Volkmer A, Schöndorf T, Breidenbach M. Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage. J Minim Invasive Gynecol. 2011;18(6):774–778.
    1. Early pregnancy complication and abortion database [Danish] [Accessed March 13, 2019]. Available from: .
    1. Sharma JB, Roy KK, Pushparaj M, et al. Genital tuberculosis: an important cause of Asherman’s syndrome in India. Arch Gynecol Obstet. 2008;277(1):37–41.
    1. Goojha CA, Case A, Pierson R. Development of Asherman syndrome after conservative surgical management of intractable postpartum hemorrhage. Fertil Steril. 2010;94(3):1098.e1–1098.e5.
    1. Tonguc EA, Var T, Yilmaz N, Batioglu S. Intrauterine device or estrogen treatment after hysteroscopic uterine septum resection. Int J Gynaecol Obstet. 2010;109(3):226–229.
    1. Papoutsis D, Georgantzis D, Daccò MD, et al. A rare case of Asherman’s syndrome after open myomectomy: sonographic investigations and possible underlying mechanisms. Gynecol Obstet Invest. 2014;77(3):194–200.
    1. Song D, Liu Y, Xiao Y, Li T-C, Zhou F, Xia E. A matched cohort study comparing the outcome of intrauterine adhesiolysis for Asherman’s syndrome after uterine artery embolization or surgical trauma. J Minim Invasive Gynecol. 2014;21(6):1022–1028.
    1. Yu X, Yuhan L, Dongmei S, Enlan X, Tinchiu L. The incidence of postoperative adhesion following transection of uterine septum: a cohort study comparing three different adjuvant therapies. Eur J Obstet Gynecol Reprod Biol. 2016;201:61–64.
    1. di Spiezio Sardo A, Calagna G, Scognamiglio M, O’Donovan P, Campo R, de Wilde RL. Prevention of intrauterine post-surgical adhesions in hysteroscopy. A systematic review. Eur J Obstet Gynecol Reprod Biol. 2016;203:182–192.
    1. Roma Dalfó A, Úbeda B, Úbeda A, et al. Diagnostic value of hysterosal-pingography in the detection of intrauterine abnormalities: a comparison with hysteroscopy. AJR Am J Roentgenol. 2004;183(5):1405–1409.
    1. Soares SR, Barbosa dos Reis MM, Camargos AF. Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases. Fertil Steril. 2000;73(2):406–411.
    1. St L, Ramsay P, Pierson R, et al. Endometrial thickness measured by ultrasound in women with uterine outlet obstruction due to intrauterine or upper cervical adhesions. Human Reprod. 2008;23(2):306–309.
    1. Salle B, Gaucherand P, de Saint Hilaire P, Rudigoz RC. Transvaginal sonohysterographic evaluation of intrauterine adhesions. J Clin Ultrasound. 1999;27(3):131–134.
    1. Berridge DL, Winter TC. Saline infusion sonohysterography: technique, indications, and imaging findings. J Ultrasound Med. 2004;23(1):97–112.
    1. Kim MJ, Lee Y, Lee C, et al. Accuracy of three dimensional ultrasound and treatment outcomes of intrauterine adhesion in infertile women. Taiwan J Obstet Gynecol. 2015;54(6):737–741.
    1. Tesarik J, Mendoza-Tesarik R, Mendoza N. Virtual ultrasonographic hysteroscopy followed by conventional operative hysteroscopy, enabling pregnancy. Am J Obstet Gynecol. 2017;216(2):188.e1.
    1. Letterie GS, Haggerty MF. Magnetic resonance imaging of intrauterine synechiae. Gynecol Obstet Invest. 1994;37(1):66–68.
    1. Bacelar AC, Wilcock D, Powell M, Worthington BS. The value of MRI in the assessment of traumatic intra-uterine adhesions (Asherman’s syndrome) Clin Radiol. 1995;50(2):80–83.
    1. Yan L, Wang A, Bai R, et al. Application of SonoVue combined with three-dimensional color power angiography in the diagnosis and prognosis evaluation of intrauterine adhesion. Eur J Obstet Gynecol Reprod Biol. 2016;198:68–72.
    1. March CM, Israel R, March AD. Hysteroscopic management of intrauterine adhesions. Am J Obstet Gynecol. 1978;130(6):653–657.
    1. Hamou J, Salat-Baroux J, Siegler AM. Diagnosis and treatment of intrauterine adhesions by microhysteroscopy. Fertil Steril. 1983;39(3):321–326.
    1. Valle RF, Sciarra JJ. Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome. Am J Obstet Gynecol. 1988;158(6 Pt 1):1459–1470.
    1. The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Müllerian anomalies and intrauterine adhesions Fertil Steril. 1988;49(6):944–955.
    1. Donnez J, Nisolle M. Hysteroscopic adhesiolysis of intrauterine adhesions (Asherman syndrome) In: Donnez J, editor. Atlas of Laser Operative Laparoscopy and Hysteroscopy. London, UK: Parthenon Publishing Group; 1994. pp. 305–322.
    1. Wamsteker K. Diagnostic hysteroscopy: technique and documentation. In: Sutton CD, Diamond M, editors. Endoscopic Surgery for Gynecologists. London, UK: WB Saunders; 1998. pp. 511–524.
    1. Nasr AL, Al-Inany HG, Thabet SM, Aboulghar M. A clinicohysteroscopic scoring system of intrauterine adhesions. Gynecol Obstet Invest. 2000;50(3):178–181.
    1. Li X, Wu L, Zhou Y, et al. New crosslinked hyaluronan gel for the prevention of intrauterine adhesions after dilation and curettage in patients with delayed miscarriage: a prospective, multicenter, randomized, controlled trial. J Minim Invasive Gynecol. 2019;26(1):94–99.
    1. Taskin O, Sadik S, Onoglu A, et al. Role of endometrial suppression on the frequency of intrauterine adhesions after resectoscopic surgery. J Am Assoc Gynecol Laparosc. 2000;7(3):351–354.
    1. Mazzon I, Favilli A, Cocco P, et al. Does cold loop hysteroscopic myomectomy reduce intrauterine adhesions? A retrospective study. Fertil Steril. 2014;101(1):294–298.
    1. Dabirashrafi H, Mohammad K, Moghadami-Tabrizi N, Zandinejad K, Moghadami-Tabrizi M. Is estrogen necessary after hysteroscopic incision of the uterine septum? J Am Assoc Gynecol Laparosc. 1996;3(4):623–625.
    1. Roy KK, Negi N, Subbaiah M, Kumar S, Sharma JB, Singh N. Effectiveness of estrogen in the prevention of intrauterine adhesions after hysteroscopic septal resection: a prospective, randomized study. J Obstet Gynaecol Res. 2014;40(4):1085–1088.
    1. Healy MW, Schexnayder B, Connell MT, et al. Intrauterine adhesion prevention after hysteroscopy: a systematic review and meta-analysis. Am J Obstet Gynecol. 2016;215(3):267–275.
    1. Sugimoto O. Diagnostic and therapeutic hysteroscopy for traumatic intrauterine adhesions. Am J Obstet Gynecol. 1978;131(5):539–547.
    1. Pabuçcu R, Atay V, Orhon E, Urman B, Ergün A. Hysteroscopic treatment of intrauterine adhesions is safe and effective in the restoration of normal menstruation and fertility. Fertil Steril. 1997;68(6):1141–1143.
    1. Fernandez H, Gervaise A, de Tayrac R. Operative hysteroscopy for infertility using normal Saline solution and a coaxial bipolar electrode: a pilot study. Hum Reprod. 2000;15(8):1773–1775.
    1. Newton JR, Mackenzie WE, Emens MJ, Jordan JA. Division of uterine adhesions (Asherman’s syndrome) with the Nd-YAG laser. Br J Obs Gyn. 1989;96(1):102–104.
    1. Chapman R, Chapman K. The value of two stage laser treatment for severe Asherman’s syndrome. Br J Obstet Gynaecol. 1996;103(12):1256–1258.
    1. Istre O, Bjoennes J, Naess R, Hornbaek K, Forman A. Postoperative cerebral oedema after transcervical endometrial resection and uterine irrigation with 1.5% glycine. Lancet. 1994;344(8931):1187–1189.
    1. Capella-Allouc S, Morsad F, Rongières-Bertrand C, Taylor S, Fernandez H. Hysteroscopic treatment of severe Asherman’s syndrome and subsequent fertility. Hum Reprod. 1999;14(5):1230–1233.
    1. Yamamoto N, Takeuchi R, Izuchi D, et al. Hysteroscopic adhesiolysis for patients with Asherman’s syndrome: menstrual and fertility outcomes. Reprod Med Biol. 2013;12(4):159–166.
    1. Bougie O, Lortie K, Shenassa H, Chen I, Singh SS. Treatment of Asherman’s syndrome in an outpatient hysteroscopy setting. J Minim Invasive Gynecol. 2015;22(3):446–450.
    1. Broome JD, Vancaillie TG. Fluoroscopically guided hysteroscopic division of adhesions in severe Asherman syndrome. Obstet Gynecol. 1999;93(6):1041–1043.
    1. Xu W, Zhang Y, Yang Y, Zhang S, Lin X. Effect of early second-look hysteroscopy on reproductive outcomes after hysteroscopic adhesiolysis in patients with intrauterine adhesion, a retrospective study in China. Int J Surg. 2018;50:49–54.
    1. Robinson JK, Colimon LMS, Isaacson KB. Postoperative adhesiolysis therapy for intrauterine adhesions (Asherman’s syndrome) Fertil Steril. 2008;90(2):409–414.
    1. Dawood A, Al-Talib A, Tulandi T. Predisposing factors and treatment outcome of different stages of intrauterine adhesions. J Obstet Gynaecol Can. 2010;32(8):767–770.
    1. Orhue AAE, Aziken ME, Igbefoh JO. A comparison of two adjunctive treatments for intrauterine adhesions following lysis. Int J Gynaecol Obstet. 2003;82(1):49–56.
    1. Zikopoulos KA, Kolibianakis EM, Platteau P, et al. Live delivery rates in subfertile women with Asherman’s syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system. Reprod Biomed Online. 2004;8(6):720–725.
    1. Myers EM, Hurst BS. Comprehensive management of severe Asherman syndrome and amenorrhea. Fertil Steril. 2012;97(1):160–164.
    1. Salma U, Xue M, Md Sayed AS, Xu D. Efficacy of intrauterine device in the treatment of intrauterine adhesions. Biomed Res Int. 2014;2014(5):1–15.
    1. Malhotra N, Bahadur A, Kalaivani M, Mittal S. Changes in endometrial receptivity in women with Asherman’s syndrome undergoing hysteroscopic adhesiolysis. Arch Gynecol Obstet. 2012;286(2):525–530.
    1. Johary J, Xue M, Zhu X, Xu D, Velu PP. Efficacy of estrogen therapy in patients with intrauterine adhesions: systematic review. J Minim Invasive Gynecol. 2014;21(1):44–54.
    1. Thomson AJM, Abbott JA, Kingston A, Lenart M, Vancaillie TG. Fluoroscopically guided synechiolysis for patients with Asherman’s syndrome: menstrual and fertility outcomes. Fertil Steril. 2007;87(2):405–410.
    1. Liu L, Huang X, Xia E, Zhang X, Li TC, Liu Y. A cohort study comparing 4 mg and 10 mg daily doses of postoperative oestradiol therapy to prevent adhesion reformation after hysteroscopic adhesiolysis. Hum Fertil. 2018;48:1–7.
    1. Guo J, Li TC, Liu Y, et al. A prospective, randomized, controlled trial comparing two doses of oestrogen therapy after hysteroscopic adhesiolysis to prevent intrauterine adhesion recurrence. Reprod Biomed Online. 2017;35(5):555–561.
    1. Acunzo G, Guida M, Pellicano M, et al. Effectiveness of auto-cross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective, randomized, controlled study. Hum Reprod. 2003;18(9):1918–1921.
    1. Lin XN, Zhou F, Wei ML, et al. Randomized, controlled trial comparing the efficacy of intrauterine balloon and intrauterine contraceptive device in the prevention of adhesion reformation after hysteroscopic adhesiolysis. Fertil Steril. 2015;104(1):235–240.
    1. March CM. Management of Asherman’s syndrome. Reprod Biomed Online. 2011;23(1):63–76.
    1. Kilic S, Yuksel B, Pinarli F, Albayrak A, Boztok B, Delibasi T. Effect of stem cell application on Asherman syndrome, an experimental rat model. J Assist Reprod Genet. 2014;31(8):975–982.
    1. Alawadhi F, Du H, Cakmak H, Taylor HS. Bone marrow-derived stem cell (BMDSC) transplantation improves fertility in a murine model of Asherman’s syndrome. PLoS One. 2014;9(5):e96662.
    1. Wang J, Ju B, Pan C, et al. Application of bone marrow-derived mesenchymal stem cells in the treatment of intrauterine adhesions in rats. Cell Physiol Biochem. 2016;39(4):1553–1560.
    1. Gan L, Duan H, Xu Q, et al. Human amniotic mesenchymal stromal cell transplantation improves endometrial regeneration in rodent models of intrauterine adhesions. Cytotherapy. 2017;19(5):603–616.
    1. Domnina A, Novikova P, Obidina J, et al. Human mesenchymal stem cells in spheroids improve fertility in model animals with damaged endometrium. Stem Cell Res Ther. 2018;9(1):50.
    1. Nagori CB, Panchal SY, Patel H. Endometrial regeneration using autologous adult stem cells followed by conception by in vitro fertilization in a patient of severe Asherman’s syndrome. J Human Reprod Sci. 2011;4(1):43–48.
    1. Singh N, Mohanty S, Seth T, Shankar M, Bhaskaran S, Dharmendra S. Autologous stem cell transplantation in refractory Asherman’s syndrome: a novel cell based therapy. J Hum Reprod Sci. 2014;7(2):93–98.
    1. Santamaria X, Cabanillas S, Cervelló I, et al. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod. 2016;31(5):1087–1096.
    1. Tan J, Li P, Wang Q, et al. Autologous menstrual blood-derived stromal cells transplantation for severe Asherman’s syndrome. Hum Reprod. 2016;31(12):2723–2729.
    1. Baradwan S, Baradwan A, Bashir M, Al-Jaroudi D. The birth weight in pregnant women with Asherman syndrome compared to normal intrauterine cavity: a case-control study. Medicine. 2018;97(32):e11797.
    1. Friedman A, Defazio J, Decherney A. Severe obstetric complications after aggressive treatment of Asherman syndrome. Obstet Gynecol. 1986;67(6):864–867.
    1. Siegler AM, Valle RF. Therapeutic hysteroscopic procedures. Fertil Steril. 1988;50(5):685–701.
    1. Engelbrechtsen L, Langhoff-Roos J, Kjer JJ, Istre O. Placenta accreta: adherent placenta due to Asherman syndrome. Clin Case Rep. 2015;3(3):175–178.
    1. Thinkhamrop J, Laopaiboon M, Lumbiganon P. Prophylactic antibiotics for transcervical procedures. Cochrane Database Syst Rev. 2007;3:CD005637.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner